Physician profile
Isaac L Moss
NPI 1013222660
$676,057.67
in general payments reported to CMS, 2019-2025
26 companies · $120K in 2025
The $120K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $81K · 2021: $125K · 2022: $81K · 2023: $96K · 2024: $125K · 2025: $120K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $176K · Consulting Fee: $142K · Travel and Lodging: $16K · Food and Beverage: $6,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $176,411.51 |
| Consulting Fee | $142,207.40 |
| Travel and Lodging | $16,199.63 |
| Food and Beverage | $6,553.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $332,622.70 | 2019-2025 | Invictus Open, Safeop, Other - Miscellaneous |
| Stryker Corporation | $164,548.53 | 2019-2025 | Cascadia Interbody System, Canyon Retractor Systems, Monterey Al |
| Spinal Simplicity, LLC | $108,338.36 | 2019-2024 | Ha Minuteman G3-R |
| Spine Wave, INC. | $21,140.33 | 2021-2025 | Salvo Spine System, Spinal Implant |
| Spineart Sa | $16,054.00 | 2019-2022 | |
| Cerapedics INC. | $13,687.70 | 2021-2025 | I-Factor Peptide Enhanced Bone Graft |
| Biedermann Motech, INC. | $11,870.61 | 2019-2024 | Telix K Interbody System |
| Arthrex, INC. | $1,396.96 | 2019-2020 | |
| Nuvasive, INC. | $1,381.03 | 2019-2023 | Xlif |
| Si-Bone, INC. | $1,076.43 | 2019-2025 | |
| Integrity Implants INC. | $911.23 | 2022 | |
| Augmedics INC. | $769.76 | 2022-2025 | Xvision |
| Atlas Spine, INC. | $500.00 | 2019 | |
| Depuy Synthes Sales INC. | $302.75 | 2025 | Velys, Trialtis |
| Curiteva, INC. | $295.84 | 2024-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intrinsic Therapeutics | $261.47 | 2025 | Barricaid Acd (Annular Closure Device) |
| Vb Spine LLC | $253.41 | 2025 | Everest Spinal System |
| Medtronic, INC. | $131.38 | 2022 | |
| Globus Medical, INC. | $115.59 | 2024-2025 | Alif Instruments (Universal), Elsa |
| Smith+Nephew, INC. | $104.11 | 2024 | Pico 14 |
| Carlsmed, INC. | $88.08 | 2022 | |
| Surgalign Spine Technologies, INC. | $75.43 | 2021-2022 | |
| Orthofix Medical, INC. | $62.57 | 2023 | Spinal-Stim, Spinal-Stim |
| Icotec Medical INC. | $26.94 | 2025 | Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm |
| Sanara Medtech INC. | $23.00 | 2023 | Celleraterx |
| Pfizer INC. | $19.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$567,291.69 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.